Almost nearing our 10th anniversary, at Nemaura Medical we pride ourselves in developing affordable diagnostic and digital tools for a wide range of medical conditions.
Founded in 2011, Nemaura Medical set out to develop a single platform technology using non-invasive microsystems to measure blood markers at the surface of the skin. Since then, the company has evolved with the creation of wearable technologies and digital healthcare solutions that encourage and empower people to take charge of their own health and wellbeing.
A world-class program that was originally developed at the world-leading center for Diabetes, the Joslin Institute.
This is a digital program that comes with over a decade of clinical evidence demonstrating excellent efficacy. We have combined this with our glucose-monitoring platform to bring an outstanding product to market to help people with diabetes manage their condition and potentially reverse Type 2 diabetes.Visit BEAT®diabetes
With over 420 million people worldwide with diabetes and the number of pre-diabetes cases at almost three times this number, diabetes is an urgent global health crisis.
Combining clinical research with patient-friendly technology, sugarBEAT® delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management.Show more
The sugarBEAT® device is a world-first in non-invasive continuous glucose monitoring suitable for people with both type 1 and Type 2 Diabetes as well as Pre-diabetes. The device, which is a CE approved Class IIb medical device, sits on the top of the arm and measures blood glucose levels once every 5 minutesVisit sugarBEAT®
Lactic acid is a key performance indicator for the body and a guide to how well muscles react to long term exertion and recovery. Well-trained athletes and regular sports players are very efficient at faster lactate ‘recycling’ for extra energy (ATP). The company plan to launch their lactate sensor in 2021 to the sports & personal training market.
Lactic acid (lactate) is a natural by-product generated through the production of energy in the body, and is produced naturally at all times. The relationship of lactic acid to the ability of the body to perform must be assessed in two parts: the function of the lactate itself, and the adverse effects of the hydrogen ion produced in the reaction that creates lactic acid.Show more
Lactate threshold testing data can be used as a starting point or in conjunction with more specific testing measures, including metabolic (VO2 max) testing. Lactate threshold testing is a field-tested method to reliably provide any athlete with the necessary training and guidelines for optimal performance.
Lactate Threshold monitoring/testing especially benefits endurance athletes, such as:
An increase in blood lactate levels is also a marker of critical disease states. Recent publications have indicated the presence of elevated lactate levels in patients with COVID-19 infection.
Continuous lactate monitoring has applications in various disease states and critical care including the monitoring of progression in viral infection, sepsis and septic shock and COVID-19 infection.
Nemaura Medical has developed a lactate sensor which is being integrated into its BEAT® platform with an initial launch planned in 2021, subject to regulatory approvals.
A person’s body temperature says a lot about their health.
Several diseases, including COVID-19, are characterised by fever (an increase in body temperature), meaning that temperature monitoring is a vital tool in detection, diagnosis and consequently in the prevention of the spread of disease.
Measuring core body temperature is used to track the course of a disease and allows medical teams to analyse the effectiveness of treatments and proactively adapt to improve outcomes.Show more
Body temperature monitoring plays an important role in fertility as it helps women and couples better understand fertility and the ovulation cycle and is therefore a powerful ally in providing the best chance of conception.
Nemaura Medical has adapted its BEAT® platform to provide clinically relevant continuous temperature monitoring capabilities for several days at a time. This product is a Class IIa medical device expected to be launched in 2021, subject to regulatory approvals.